FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205522876> ?p ?o ?g. }

• W3205522876 abstract "Glucagon Like Peptide-1 Receptor (GLP-1R) activation reduces pro-inflammatory responses of human monocytes, their accumulation in the vascular wall and foam cell formation inhibiting atherosclerogenesis. This suggests that reduction of circulating GLP-1-1R positive monocytes may have pro-atherogenic effects. It is unknown whether different CD14/CD16 monocytes subsets display GLP-1R and whether their relative proportions correlate with atherosclerosis severity. We evaluated the association between GLP-1R positivity in different CD14/CD16 monocyte subsets and coronary atherosclerosis severity. Relative amounts of classical (CD14+/CD16-), intermediate pro-inflammatory (CD14+/CD16+) and non-classical patrolling (CD14-/CD16+) subsets of total circulating monocytes and the proportions of GLP-1R positive monocytes in these subsets were determined in 13 control subjects and 10 dyslipidemic ischemic heart disease (IHD) patients with severe angiographic proven coronary atherosclerosis using flow cytometry analysis. Atherosclerosis severity was calculated by SYNTAX score. In univariable analysis, severe atherosclerosis was associated with decreased proportion of classical monocytes and two fold increased CD16+ pro-inflammatory and patrolling subsets as compared with controls (p = 0.01, p = 0.02 and p = 0.01, respectively). Frequency of GLP-1R positive monocytes was decreased in both CD16+ subsets (p = 0.02 and p = 0.05, respectively) and negatively correlated with atherosclerosis severity (r = −0.65, p = 0.005 and r = −0.44, p = 0.05, respectively). Increased skewing of the classical monocyte population toward CD16+ pro-inflammatory and patrolling subsets accompanied by decreased in GLP-1R positivity are associated with coronary atherosclerosis severity in IHD patients with dyslipidemia. Although the effect of potential confounders cannot be ruled out, our data suggest that failure of GLP-1R-dependent anti-inflammatory/anti-atherogenic control results in innate immune system dysfunction and can promote atherosclerogenesis." @default.
• W3205522876 created "2021-10-25" @default.
• W3205522876 creator A5000010261 @default.
• W3205522876 creator A5011150158 @default.
• W3205522876 creator A5030753941 @default.
• W3205522876 creator A5038895897 @default.
• W3205522876 creator A5059837027 @default.
• W3205522876 creator A5068513451 @default.
• W3205522876 creator A5071524792 @default.
• W3205522876 creator A5082090033 @default.
• W3205522876 creator A5085587260 @default.
• W3205522876 date "2021-10-01" @default.
• W3205522876 modified "2023-10-16" @default.
• W3205522876 title "Coronary atherosclerosis severity is closely associated with decreased GLP-1R positivity among CD16+ pro-inflammatory and patrolling monocyte subsets" @default.
• W3205522876 cites W1233989772 @default.
• W3205522876 cites W150221401 @default.
• W3205522876 cites W1535151445 @default.
• W3205522876 cites W1838502448 @default.
• W3205522876 cites W1964369726 @default.
• W3205522876 cites W1965859404 @default.
• W3205522876 cites W1965929613 @default.
• W3205522876 cites W1973837946 @default.
• W3205522876 cites W1984378291 @default.
• W3205522876 cites W1997393792 @default.
• W3205522876 cites W2001432332 @default.
• W3205522876 cites W2004456679 @default.
• W3205522876 cites W2011232682 @default.
• W3205522876 cites W2039792707 @default.
• W3205522876 cites W2048380290 @default.
• W3205522876 cites W2076370920 @default.
• W3205522876 cites W2079724669 @default.
• W3205522876 cites W2082956804 @default.
• W3205522876 cites W2108670276 @default.
• W3205522876 cites W2112187949 @default.
• W3205522876 cites W2116422482 @default.
• W3205522876 cites W2126982981 @default.
• W3205522876 cites W2127385800 @default.
• W3205522876 cites W2129909114 @default.
• W3205522876 cites W2134685432 @default.
• W3205522876 cites W2142097676 @default.
• W3205522876 cites W2148401875 @default.
• W3205522876 cites W2155444336 @default.
• W3205522876 cites W2158667202 @default.
• W3205522876 cites W2159381973 @default.
• W3205522876 cites W2161148699 @default.
• W3205522876 cites W2162405407 @default.
• W3205522876 cites W2165073428 @default.
• W3205522876 cites W2170856157 @default.
• W3205522876 cites W2193451828 @default.
• W3205522876 cites W2321992706 @default.
• W3205522876 cites W2476067827 @default.
• W3205522876 cites W2533310720 @default.
• W3205522876 cites W2602595000 @default.
• W3205522876 cites W2743567633 @default.
• W3205522876 cites W2759148736 @default.
• W3205522876 cites W2900653572 @default.
• W3205522876 cites W2901979245 @default.
• W3205522876 cites W2911168101 @default.
• W3205522876 cites W2945278503 @default.
• W3205522876 cites W2980829193 @default.
• W3205522876 cites W4240818984 @default.
• W3205522876 doi "https://doi.org/10.1016/j.athplu.2021.10.001" @default.
• W3205522876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36643724" @default.
• W3205522876 hasPublicationYear "2021" @default.
• W3205522876 type Work @default.
• W3205522876 sameAs 3205522876 @default.
• W3205522876 citedByCount "0" @default.
• W3205522876 crossrefType "journal-article" @default.
• W3205522876 hasAuthorship W3205522876A5000010261 @default.
• W3205522876 hasAuthorship W3205522876A5011150158 @default.
• W3205522876 hasAuthorship W3205522876A5030753941 @default.
• W3205522876 hasAuthorship W3205522876A5038895897 @default.
• W3205522876 hasAuthorship W3205522876A5059837027 @default.
• W3205522876 hasAuthorship W3205522876A5068513451 @default.
• W3205522876 hasAuthorship W3205522876A5071524792 @default.
• W3205522876 hasAuthorship W3205522876A5082090033 @default.
• W3205522876 hasAuthorship W3205522876A5085587260 @default.
• W3205522876 hasBestOaLocation W32055228761 @default.
• W3205522876 hasConcept C114684123 @default.
• W3205522876 hasConcept C126322002 @default.
• W3205522876 hasConcept C134018914 @default.
• W3205522876 hasConcept C147483822 @default.
• W3205522876 hasConcept C167672396 @default.
• W3205522876 hasConcept C203014093 @default.
• W3205522876 hasConcept C2778213512 @default.
• W3205522876 hasConcept C2778513237 @default.
• W3205522876 hasConcept C2781184567 @default.
• W3205522876 hasConcept C2781462264 @default.
• W3205522876 hasConcept C553184892 @default.
• W3205522876 hasConcept C71924100 @default.
• W3205522876 hasConceptScore W3205522876C114684123 @default.
• W3205522876 hasConceptScore W3205522876C126322002 @default.
• W3205522876 hasConceptScore W3205522876C134018914 @default.
• W3205522876 hasConceptScore W3205522876C147483822 @default.
• W3205522876 hasConceptScore W3205522876C167672396 @default.
• W3205522876 hasConceptScore W3205522876C203014093 @default.
• W3205522876 hasConceptScore W3205522876C2778213512 @default.
• W3205522876 hasConceptScore W3205522876C2778513237 @default.
• W3205522876 hasConceptScore W3205522876C2781184567 @default.
• W3205522876 hasConceptScore W3205522876C2781462264 @default.

• next